THMO logo

ThermoGenesis Holdings (THMO) Company Overview

Profile

Full Name:

ThermoGenesis Holdings, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

June 5, 1987

Indexes:

Not included

Website:

http://www.thermogenesis.com

Description:

ThermoGenesis Holdings (THMO) is a biotechnology company that develops and sells products for cell and tissue processing. Their focus is on regenerative medicine, helping to improve treatments for various medical conditions by using advanced technologies to process and store cells for therapeutic use.

Key Details

Price

$0.00

Market Cap

$2385.84(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.45 M(-9.90% YoY)

Annual EPS

-$7.59(+62.89% YoY)

PE Ratio

-

Annual ROE

1078.28%

Annual Debt To Equity

-4.59

Beta

-4.00

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 12, 2021

Recent annual earnings:

Mar 17, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 22, 2022

Analyst ratings

Recent major analysts updates

Nov 14, 23 HC Wainwright & Co.
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
May 16, 23 HC Wainwright & Co.
Buy
Apr 3, 23 HC Wainwright & Co.
Buy
Aug 12, 22 HC Wainwright & Co.
Buy
Nov 13, 20 HC Wainwright & Co.
Buy
Apr 17, 20 H.C. Wainwright
Buy

Screeners with THMO included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Best performing stocks last 3 months
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.00
THMO price is $0.00

Price All-time High

$230399.81
THMO price is currently -100.00% below its historical high of $230399.81

Price Analysts Target

-
THMO price consensus analysts' forecast is unknown

Price Most Recent Change

-57.14%
THMO price was down -57.14% on Feb 6, 2025

Price YTD Change

-57.14%
THMO price is down -57.14% since January 1st

Price 3-Year Change

-100%
THMO price is down -100% over the past 3 years

Market cap

Market Cap

$2385.84
THMO market capitalization is $2385.84

Market Cap 3-Year Change

-99.98%
THMO market capitalization is down -99.98% over the past 3 years

Market Cap All-time High

$298.12 M
THMO market capitalization is currently -100.00% below its historical high of $298.12 million

Market Cap Sector Rank

0.73%
THMO market capitalization is higher than 0.73% of companies in Healthcare sector

Technical

Beta

-4.00
THMO beta is -4.00

200-day SMA

$0.20
THMO price is currently -99.85% below its 200-day simple moving average

14-day RSI

50.00
THMO 14-day relative strength index is 50.00

30-day Relative Volume

5.78
THMO 30-day relative volume is 5.78

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$9.45 M
THMO annual revenue is $9.45 million

Annual Revenue Analysts Estimate

$16.90 M
THMO annual revenue is currently -44.11% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-9.9%
THMO annual revenue is down -9.9% year-on-year

Annual Revenue Sector Rank

29.57%
THMO annual revenue is higher than 29.57% of companies in Healthcare sector

Profit

Annual Gross Profit

$1.93 M
THMO annual gross profit is $1.93 million

Annual Gross Margin

20.44%
THMO annual gross profit margin is 20.44%

Annual Operating Profit

-$6.57 M
THMO annual operating income is -$6.57 million

Annual Operating Margin

-69.60%
THMO annual operating profit margin is -69.60%

Annual Net Income

-$17.98 M
THMO annual net profit is -$17.98 million

Annual Net Margin

-190.31%
THMO annual net profit margin is -190.31%

EPS

Annual EPS

-$7.59
THMO annual earnings per share is -$7.59

Annual EPS Analysts Estimate

-
THMO annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

+62.89%
THMO annual earnings per share is up +62.89% year-on-year

Annual EPS Sector Rank

17.43%
THMO annual earnings per share is higher than 17.43% of companies in Healthcare sector

ROA & ROE

Annual ROA

-117.41%
THMO annual return on assets is -117.41%

Annual ROE

1078.28%
THMO annual return on equity is 1078.28%

EBIT & EBITDA

Annual EBIT

-$8.89 M
THMO annual earnings before interest & taxes is -$8.89 million

Annual EBITDA

-$7.74 M
THMO annual EBITDA is -$7.74 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
THMO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
THMO price to earnings ratio is unknown

PB Ratio

PB Ratio

0.00
THMO price to book ratio is 0.00

PB Ratio Sector Rank

16.83%
THMO price to book ratio is higher than 16.83% of companies in Healthcare sector

PS Ratio

PS Ratio

0.00
THMO price to sales ratio is 0.00

PS Ratio Sector Rank

1.29%
THMO price to sales ratio is higher than 1.29% of companies in Healthcare sector

Enterprise value

Enterprise Value

$5.75 M
THMO enterprise value is $5.75 million

Enterprise Value Sector Rank

19.01%
THMO enterprise value is higher than 19.01% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.83
THMO EV/EBITDA is -0.83

EV/EBITDA Sector Rank

49.52%
THMO EV/EBITDA is higher than 49.52% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.44
THMO annual current ratio is 0.44

Annual Quick Ratio

0.32
THMO annual quick ratio is 0.32

Leverage

Annual Debt To Equity

-4.59
THMO annual debt to equity ratio is -4.59

Annual Interest Coverage Ratio

-0.89
THMO annual interest coverage ratio is -0.89

Risk & Stability

Piotroski F-Score

4
THMO piotroski f-score is 4

Altman Z-Score

-37.89
THMO altman z-score is -37.89

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$11.23 M
THMO annual total assets is $11.23 million

Annual Non Current Assets

$6.05 M
THMO annual long term assets is $6.05 million

Annual Current Assets

$5.18 M
THMO annual total current assets is $5.18 million

Annual Cash & Cash Equivalents

$2.00 M
THMO annual cash & cash equivalents is $2.00 million

Equity

Annual Book Value

-$1.67 M
THMO annual book value is -$1.67 million

Annual Working Capital

-$6.58 M
THMO annual working capital is -$6.58 million

Liabilities

Annual Total Liabilities

$14.82 M
THMO annual total liabilities is $14.82 million

Annual Total Long Term Liabilities

$3.05 M
THMO annual total long term liabilities is $3.05 million

Annual Current Liabilities

$11.76 M
THMO annual total current liabilities is $11.76 million

Annual Accounts Payable

$948.00 K
THMO annual accounts payable is $948.00 thousand

Debt

Annual Total Debt

$10.56 M
THMO annual total debt is $10.56 million

Annual Total Debt 1-Year Change

+1.84%
THMO annual total debt is up +1.84% year-on-year

Annual Long Term Debt

$2.90 M
THMO annual long term debt is $2.90 million

Annual Short Term Debt

$7.66 M
THMO annual short term debt is $7.66 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$16.02 M
THMO annual total expenses is $16.02 million

Annual Operating Expenses

$8.51 M
THMO annual total operating expenses is $8.51 million

Annual Cost Of Goods Sold

$7.51 M
THMO annual cost of goods sold is $7.51 million

Annual SGA

$7.22 M
THMO annual SGA is $7.22 million

Annual D&A

$1.15 M
THMO annual depreciation & amortization is $1.15 million

Annual Interest Expense

$10.03 M
THMO annual interest expense is $10.03 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$3.72 M
THMO annual cash flow from operations is -$3.72 million

Annual CFO 1-Year Change

+48.91%
THMO annual cash flow from operations is up +48.91% year-on-year

Annual CFI

-$1.73 M
THMO annual cash flow from investing activities is -$1.73 million

Annual CFI 1-Year Change

-333.25%
THMO annual cash flow from investing activities is down -333.25% year-on-year

Annual CFF

$3.28 M
THMO annual cash flow from financing activities is $3.28 million

Annual CFF 1-Year Change

-28.52%
THMO annual cash flow from financing activities is down -28.52% year-on-year

Free CashFlow

Annual FCF

-$5.45 M
THMO annual free cash flow is -$5.45 million

Annual FCF 1-Year Change

+29.01%
THMO annual free cash flow is up +29.01% year-on-year

CAPEX

Annual CAPEX

$1.73 M
THMO annual capital expenditures is $1.73 million

Annual CAPEX 1-Year Change

+333.25%
THMO annual capital expenditures is up +333.25% year-on-year

Institutional Ownership

Similar stocks

VIVE logo
Viveve Medical (VIVE)
MTEM logo
Molecular Templates (MTEM)
NMRD logo
Nemaura Medical (NMRD)
CALA logo
Calithera Biosciences (CALA)
BIMI logo
BIMI International Medical (BIMI)
MOTS logo
Motus GI Holdings (MOTS)
EFTR logo
eFFECTOR Therapeutics (EFTR)
UTRS logo
Minerva Surgical (UTRS)
CMAX logo
CareMax (CMAX)
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
THMO
Seeking AlphaNovember 13, 2023

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
THMO
PRNewsWireAugust 8, 2023

Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.

ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
THMO
Seeking AlphaMay 15, 2023

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter ended March 31, 2023.

FAQ

  • What is the ticker symbol for ThermoGenesis Holdings?
  • Does ThermoGenesis Holdings pay dividends?
  • What sector is ThermoGenesis Holdings in?
  • What industry is ThermoGenesis Holdings in?
  • What country is ThermoGenesis Holdings based in?
  • When did ThermoGenesis Holdings go public?
  • Is ThermoGenesis Holdings in the S&P 500?
  • Is ThermoGenesis Holdings in the NASDAQ 100?
  • Is ThermoGenesis Holdings in the Dow Jones?
  • When was ThermoGenesis Holdings's last earnings report?
  • When does ThermoGenesis Holdings report earnings?

What is the ticker symbol for ThermoGenesis Holdings?

The ticker symbol for ThermoGenesis Holdings is NASDAQ:THMO

Does ThermoGenesis Holdings pay dividends?

No, ThermoGenesis Holdings does not pay dividends

What sector is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Healthcare sector

What industry is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Medical Devices industry

What country is ThermoGenesis Holdings based in?

ThermoGenesis Holdings is headquartered in United States

When did ThermoGenesis Holdings go public?

ThermoGenesis Holdings's initial public offering (IPO) was on June 5, 1987

Is ThermoGenesis Holdings in the S&P 500?

No, ThermoGenesis Holdings is not included in the S&P 500 index

Is ThermoGenesis Holdings in the NASDAQ 100?

No, ThermoGenesis Holdings is not included in the NASDAQ 100 index

Is ThermoGenesis Holdings in the Dow Jones?

No, ThermoGenesis Holdings is not included in the Dow Jones index

When was ThermoGenesis Holdings's last earnings report?

ThermoGenesis Holdings's most recent earnings report was on Aug 12, 2021

When does ThermoGenesis Holdings report earnings?

The date for ThermoGenesis Holdings's next earnings report has not been announced yet